# Eliezer M. Van Allen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eliezer-m-van-allen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 83,821 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 115 |
| i10-index | 287 |
| Last Known Institution | Broad Institute |
| OpenAlex ID | https://openalex.org/A5039044023 |
| ORCID iD | 0000-0002-0201-4444 |
| Works | 1,468 |

## Researcher papers

Showing 12 of 21.

- [Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq](https://scholariq.org/papers/dissecting-the-multicellular-ecosystem-of-metastatic-melanoma-by-single-cell-rna/)
- [Integrative Clinical Genomics of Advanced Prostate Cancer](https://scholariq.org/papers/integrative-clinical-genomics-of-advanced-prostate-cancer/)
- [Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade](https://scholariq.org/papers/clonal-neoantigens-elicit-t-cell-immunoreactivity-and-sensitivity-to-immune/)
- [Genomic correlates of response to CTLA-4 blockade in metastatic melanoma](https://scholariq.org/papers/genomic-correlates-of-response-to-ctla-4-blockade-in-metastatic-melanoma/)
- [Comprehensive Characterization of Cancer Driver Genes and Mutations](https://scholariq.org/papers/comprehensive-characterization-of-cancer-driver-genes-and-mutations/)
- [Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/integrated-genomic-characterization-of-pancreatic-ductal-adenocarcinoma/)
- [AACR Project GENIE: Powering Precision Medicine through an International Consortium](https://scholariq.org/papers/aacr-project-genie-powering-precision-medicine-through-an-international/)
- [Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer](https://scholariq.org/papers/inherited-dna-repair-gene-mutations-in-men-with-metastatic-prostate-cancer/)
- [A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade](https://scholariq.org/papers/a-cancer-cell-program-promotes-t-cell-exclusion-and-resistance-to-checkpoint/)
- [Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma](https://scholariq.org/papers/integrative-molecular-and-clinical-modeling-of-clinical-outcomes-to-pd1-blockade/)
- [Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma](https://scholariq.org/papers/genomic-correlates-of-immune-cell-infiltrates-in-colorectal-carcinoma/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Broad Institute](https://scholariq.org/institutions/broad-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.